Trial intelligence / Profile preview

Image-Based Functionally Adapted Radiation Therapy for Lung Cancer

NCT06925295Phase 2Recruiting

Start
Aug 2025
Primary completion
Jan 2027
Countries
1
01

Overview

Phase 2, open-label trial in lung cancer (2 arms). Primary endpoints: Incidence of PFT evidence of radiation pneumonitis at 6 months and Lung function change on spirometry at 6 months. Started Aug 2025; status: recruiting.

02

Conditions

lung cancer

Beyond the preview

Go deeper on NCT06925295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06925295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call